Skip to content

Effects of oral lactase on feeding and growth of very premature infants: a prospective cohort study

Effects of oral lactase on feeding and growth of very premature infants: a prospective cohort study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076218
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

feeding intolerance in very preterm infants

Interventions

observation group:Oral lactase
control group:none

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 0.1 Years

Inclusion criteria

Inclusion criteria: 1. Very preterm infants with gestational age of 28 to 31+6 weeks, regardless of gender; 2. Nutritional enteral feeding (>15ml/kg/d) has begun; 3. The legal guardian agreed to participate in this clinical study and voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe congenital malformations such as digestive tract malformations or 1 min Apgar score <= 7; 2. Hypereosinophilia in the blood, accompanied by symptoms of milk protein allergy, such as rash, blood in the stool; 3. Children diagnosed with neonatal necrotizing enterocolitis (NEC) stage IIb and above; 4. The legal guardian is unwilling to sign the informed consent; 5. Discontinue treatment.

Design outcomes

Secondary

MeasureTime frame
The number of days on which full enteral feeding was achieved;Albumin value;hospital stay;Growth and development indicators;

Primary

MeasureTime frame
Incidence of feeding intolerance;

Countries

China

Contacts

Public ContactChen Jingjing

Peking University Shenzhen Hospital

66116874@qq.com+86 152 1776 5659

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026